Thomas Malley - 03 Jun 2025 Form 4 Insider Report for Kiniksa Pharmaceuticals International, plc (KNSA)

Role
Director
Signature
/s/ Madelyn Zeylikman, Attorney-in-Fact
Issuer symbol
KNSA
Transactions as of
03 Jun 2025
Net transactions value
$0
Form type
4
Filing time
05 Jun 2025, 17:02:16 UTC
Previous filing
07 Jun 2024
Next filing
06 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Malley Thomas Director 23 OLD BOND STREET, THIRD FLOOR, LONDON, UNITED KINGDOM /s/ Madelyn Zeylikman, Attorney-in-Fact 05 Jun 2025 0001403322

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KNSA Class A Ordinary Shares Options Exercise +3,173 +34% 12,546 05 Jun 2025 Direct F1
holding KNSA Class A Ordinary Shares 71,967 03 Jun 2025 See footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KNSA Share Option Award $0 +16,798 $0.000000 16,798 03 Jun 2025 Class A Ordinary Shares 16,798 $29.11 Direct F3
transaction KNSA Restricted Share Units Award $0 +2,799 $0.000000 2,799 03 Jun 2025 Class A Ordinary Shares 2,799 Direct F1, F4
transaction KNSA Restricted Share Units Options Exercise $0 -3,173 -100% $0.000000 0 05 Jun 2025 Class A Ordinary Shares 3,173 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.
F2 Mr. Malley is the president of Mossrock Capital, LLC (Mossrock) and may be deemed to beneficially own the shares owned by Mossrock.
F3 The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of the grant with the final installment vesting on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is June 3, 2025.
F4 The RSUs vest in their entirety on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is June 3, 2025.
F5 The RSUs vested in a single installment on June 5, 2025; there was no expiration date for the RSUs.